Reduction of the risk of PML in natalizumab treated MS patients in Sweden: an effect of improved PML risk surveillance

Publication date: Available online 11 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Stina Kågström, Anna Fält, Anders Berglund, Fredrik Piehl, Tomas Olsson, Jan Lycke
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research